Form 4: Tenet Healthcare Director James L. Bierman Acquires Restricted Stock Units

Director James L. Bierman acquired 1,551 restricted stock units of Tenet Healthcare Corp on May 23, 2024, which vest on the first anniversary of the grant date.

Summary

• James L. Bierman, a director of Tenet Healthcare Corp, acquired 1,551 restricted stock units on May 23, 2024.
• These restricted stock units were granted under the company's Stock Incentive Plan.
• Each restricted stock unit represents the economic equivalent of one share of Tenet Healthcare's common stock.
• The restricted stock units vest on May 23, 2025, one year after the grant date.
• Bierman has the option to receive up to 37% of these units in cash instead of shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting period of one year suggests a commitment to the company's long-term performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in the healthcare industry. It provides transparency regarding the holdings and transactions of company directors.

Comparison to Industry Standards

• Stock grants to directors are a common practice across the healthcare industry to align their interests with shareholders.
• Companies like HCA Healthcare and Universal Health Services also use stock incentive plans for their executives and directors.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder confidence.
• It aligns the director's financial interests with the company's performance, potentially benefiting shareholders.

Key Dates